Cefaclor (Alvogen, Inc.)
Welcome to the PulseAid listing for the Cefaclor drug offered from Alvogen, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Alvogen, Inc. |
| NON-PROPRIETARY NAME: | Cefaclor |
| SUBSTANCE NAME: | CEFACLOR |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2010-01-18 |
| END MARKETING DATE: | 0000-00-00 |
Cefaclor HUMAN PRESCRIPTION DRUG Details:
| Item Description | Cefaclor from Alvogen, Inc. |
| LABELER NAME: | Alvogen, Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 250(mg/1) |
| START MARKETING DATE: | 2010-01-18 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 47781-266_3232eab3-5f88-4c41-bdab-c1fd71e8dfe9 |
| PRODUCT NDC: | 47781-266 |
| APPLICATION NUMBER: | ANDA065146 |
Other CEFACLOR Pharmaceutical Manufacturers / Labelers:
